We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$424M
AUM Growth
+$18.8M
Cap. Flow
-$6.82M
Cap. Flow %
-1.61%
Top 10 Hldgs %
15.99%
Holding
311
New
46
Increased
58
Reduced
107
Closed
45

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.03M
2
MCD icon
McDonald's
MCD
+$757K
3
CL icon
Colgate-Palmolive
CL
+$417K
4
GLW icon
Corning
GLW
+$349K
5
WPC icon
W.P. Carey
WPC
+$342K

Sector Composition

Rank Sector Weight
1 Technology 18.53%
2 Industrials 16.81%
3 Healthcare 10.71%
4 Consumer Discretionary 7.02%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLNX
251
DELISTED
Xilinx Inc
XLNX
-2,184
Closed -$209K
PFPT
252
DELISTED
Proofpoint, Inc.
PFPT
-2,185
Closed -$282K
FLIR
253
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
-5,109
Closed -$269K
VAR
254
DELISTED
Varian Medical Systems, Inc.
VAR
-2,106
Closed -$251K
CELG
255
DELISTED
Celgene Corp
CELG
-9,970
Closed -$990K

Similar funds

Stanley-Laman Group's Q4 2019 Portfolio in Review

As of Q4 2019, Stanley-Laman Group held 311 positions worth $424M, up 4.6% from $405M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q4 2019 filing shows 46 new, 58 increased, 107 reduced and 45 closed positions. Its largest new stake was McDonald's: 3,817 shares worth $754K. The largest sale was Celgene Corp, an estimated $990K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q4 2019 buy was McDonald's: 3,817 shares worth $754K.
  • Stanley-Laman Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.03M increase.
  • Stanley-Laman Group's biggest Q4 2019 reduction was Tiffany & Co., cutting an estimated $591K.
  • Stanley-Laman Group fully exited Celgene Corp in Q4 2019, selling an estimated $990K.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $424M portfolio in Q4 2019.
  • Stanley-Laman Group opened 46 new positions and closed 45 in Q4 2019.
  • Stanley-Laman Group's portfolio value rose 4.6% quarter-over-quarter to $424M.

Based on Stanley-Laman Group's 13F filing for Q4 2019, filed 4 Feb 2020.